Biomind Labs Inc (BMND) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.028x

Based on the latest financial reports, Biomind Labs Inc (BMND) has a cash flow conversion efficiency ratio of 0.028x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-48.96K ≈ $-35.42K USD) by net assets (CA$-1.74 Million ≈ $-1.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Biomind Labs Inc book value and equity for net asset value and shareholders' equity analysis.

Biomind Labs Inc - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how Biomind Labs Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Biomind Labs Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biomind Labs Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
HYDROTOR SA
WAR:HDR
0.017x
Bima Sakti Pertiwi Tbk PT
JK:PAMG
0.004x
Agrogeneration
PA:ALAGR
-0.030x
Argentina Lithium & Energy Corp
V:LIT
-0.020x
HYTN INNOVATIONS INC.
F:85W0
0.029x
BSL Corp Bhd
KLSE:7221
0.024x
Energy Action Ltd
AU:EAX
-0.017x
Mint Incorporation Limited Class A Ordinary Shares
NASDAQ:MIMI
N/A

Annual Cash Flow Conversion Efficiency for Biomind Labs Inc (2021–2025)

The table below shows the annual cash flow conversion efficiency of Biomind Labs Inc from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see BMND stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CA$-1.74 Million
≈ $-1.26 Million
CA$-67.55K
≈ $-48.86K
0.039x -85.72%
2024-12-31 CA$-1.30 Million
≈ $-940.54K
CA$-354.43K
≈ $-256.39K
0.273x -49.03%
2023-12-31 CA$-1.43 Million
≈ $-1.04 Million
CA$-765.93K
≈ $-554.06K
0.535x -93.84%
2022-12-31 CA$-247.66K
≈ $-179.15K
CA$-2.15 Million
≈ $-1.56 Million
8.685x +997.29%
2021-12-31 CA$2.19 Million
≈ $1.59 Million
CA$-2.12 Million
≈ $-1.54 Million
-0.968x --

About Biomind Labs Inc

NEO:BMND Canada Biotechnology
Market Cap
$9.82 Million
CA$13.58 Million CAD
Market Cap Rank
#27116 Global
#1144 in Canada
Share Price
CA$0.18
Change (1 day)
-5.41%
52-Week Range
CA$0.01 - CA$0.35
All Time High
CA$1.90
About

Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; BMND08, a 5-Metoxi-N,N-dimethyltryptamine sublingual formulation that is in Phase II clinical… Read more